RT @sudokuvariante: @DrJBhattacharya @Apoo52105617 They argued they delayed the publication in order to have complete 1-year follow-up anal…
@DrJBhattacharya @Apoo52105617 They argued they delayed the publication in order to have complete 1-year follow-up analysis: https://t.co/BeA5Xmc7YP https://t.co/vuQDrZrnwS which they didn't apply to other arms: https://t.co/wyjCrADRBY https://t.co/GiNXeRj
RT @sudokuvariante: #principletrial follow-up duration: Doxycycline: 28 days ✅https://t.co/zidzJYis9L Azithromycin: 28 days ✅ https://t.co/…
#principletrial follow-up duration: Doxycycline: 28 days ✅https://t.co/zidzJYis9L Azithromycin: 28 days ✅ https://t.co/wyjCrADRBY Colchicine: 28 days ✅https://t.co/AM5Cm0bfEv Budesonide: 28 days ✅https://t.co/ToUQDBgsYU Ivermectin: 365 days 🤡 https://t.co/
@igoreckert @berkeleykev510 @venkmurthy I’ve seen quite a lot, incl… https://t.co/D6zdAMt445 https://t.co/3IFGWBtPSN https://t.co/5u30uPUJqx I thought usually the complaint is studies *not* reporting all-cause hospitalisation though… 😅
(BJGP) Colchicina para COVID-19 en la comunidad. https://t.co/i3TQDKvBHs. #colchicina #COVID19
(BJGP) Colchicina para COVID-19 en la comunidad. https://t.co/51tHyBiy9S. #colchicina #COVID19
RT @BJGPjournal: Colchicine for COVID-19: the PRINCIPLE trial assessed COVID-19 treatments and found that colchicine does not speed up reco…
Colchicine for COVID-19: the PRINCIPLE trial assessed COVID-19 treatments and found that colchicine does not speed up recovery in people at higher risk of complications in the community ☞ https://t.co/HWRSN2sohj Podcast: https://t.co/RxzxLojOuW Video: http
RT @BJGPjournal: The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not…
RT @BJGPjournal: The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not…
RT @BJGPjournal: The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not…
RT @BJGPjournal: The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not…
RT @BJGPjournal: The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not…
RT @BJGPjournal: COVID-19: colchicine did not improve time to recovery in people at higher risk of complications with #COVID19 in the commu…
RT @BJGPjournal: The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not…
RT @BJGPjournal: The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not…
The PRINCIPLE trial design adapts to assess different #COVID19 treatments. This new study showed that colchicine does not speed up recovery from COVID-19. https://t.co/HWRSN2sohj https://t.co/rGO20zPrNP
COVID-19: colchicine did not improve time to recovery in people at higher risk of complications with #COVID19 in the community https://t.co/HWRSN2sohj https://t.co/0xwDVKtd1P
RT @NDM_Papers: Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial https://t.co/DZMajl…
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial https://t.co/DZMajlGQIQ
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial https://t.co/4rIfRyU5aq